申请人:McCONNELL Darryl
公开号:US20120108567A1
公开(公告)日:2012-05-03
The present invention encompasses compounds of general formula (1)
wherein
R
1
to R
3
are defined as in claim
1
, which are suitable for the treatment of diseases characterised by excessive or abnormal cell proliferation, and the use thereof for preparing a medicament having the above-mentioned properties.
本发明涵盖了一般式(1)的化合物,其中R1到R3的定义如权利要求书中所述,适用于治疗由过度或异常细胞增殖所表征的疾病,并且其用于制备具有上述特性的药物。